|
Volumn 8, Issue 13, 2010, Pages 2931-2940
|
Oxazole-modified glycopeptides that target arthritis-associated class II MHC Aq and DR4 proteins
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLASS II;
CLASS II MHC;
COLLAGEN-INDUCED ARTHRITIS;
DISEASE MODELS;
GLYCOPEPTIDES;
HETEROCYCLES;
LONG-TERM GOALS;
MAJOR HISTOCOMPATIBILITY COMPLEX;
OXAZOLES;
PEPTIDE BONDS;
RHEUMATOID ARTHRITIS;
THERAPEUTIC VACCINES;
TYPE II COLLAGENS;
COLLAGEN;
MONOCLONAL ANTIBODIES;
PEPTIDES;
AMIDE;
COLLAGEN;
DIPEPTIDE;
GLYCOPEPTIDE;
HLA ANTIGEN CLASS 2;
OXAZOLE DERIVATIVE;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;
AMINO ACID SEQUENCE;
ANIMAL;
ARTICLE;
CHEMICAL STRUCTURE;
CHEMICALLY INDUCED DISORDER;
CHEMISTRY;
CONFORMATION;
DRUG DESIGN;
HUMAN;
IMMUNOLOGY;
METABOLISM;
MOLECULAR GENETICS;
MOUSE;
RHEUMATOID ARTHRITIS;
SYNTHESIS;
T LYMPHOCYTE;
AMIDES;
AMINO ACID SEQUENCE;
ANIMALS;
ARTHRITIS, RHEUMATOID;
COLLAGEN;
DIPEPTIDES;
DRUG DESIGN;
GLYCOPEPTIDES;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
HUMANS;
MICE;
MODELS, MOLECULAR;
MOLECULAR CONFORMATION;
MOLECULAR SEQUENCE DATA;
OXAZOLES;
RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND;
T-LYMPHOCYTES;
MURINAE;
MUS;
|
EID: 77953782524
PISSN: 14770520
EISSN: None
Source Type: Journal
DOI: 10.1039/c003640d Document Type: Article |
Times cited : (20)
|
References (40)
|